"dbGAP Study","dbGAP Variable","dbGAP Variable Description"
phv00095623,"Atherosclerosis Risk in Communities (ARIC) Cohort",FEF(25-75)
phv00095670,"Atherosclerosis Risk in Communities (ARIC) Cohort","FEF(25-75) Q38"
phv00002687,"Framingham Cohort","LUNG FUNCTION: FEF (25-75)"
phv00003254,"Framingham Cohort","LUNG FUNCTION: FEF (25-75)"
phv00022558,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE (LIT./SEC.) - BEST EFFORT"
phv00022575,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE (LIT./SEC.) - BEST EFFORT"
phv00022591,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE - TRIAL 1 (AVERAGE RATE OF FLOW DURING MIDDLE HALF OF AN FEV - IN MILLILITERS EXPIRED PER SECOND)"
phv00022604,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE - TRIAL 1 (AVERAGE RATE OF FLOW DURING MIDDLE HALF OF AN FEV - IN MILLILITERS EXPIRED PER SECOND)"
phv00022617,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE - TRIAL 3 (AVERAGE RATE OF FLOW DURING MIDDLE HALF OF AN FEV - IN MILLILITERS EXPIRED PER SECOND)"
phv00022630,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE - TRIAL 4 (AVERAGE RATE OF FLOW DURING MIDDLE HALF OF AN FEV - IN MILLILITERS EXPIRED PER SECOND)"
phv00022643,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE - TRIAL 5 (AVERAGE RATE OF FLOW DURING MIDDLE HALF OF AN FEV - IN MILLILITERS EXPIRED PER SECOND)"
phv00022658,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE - SUMMARY (AVERAGE RATE OF FLOW DURING MIDDLE HALF OF AN FEV - IN MILLILITERS EXPIRED PER SECOND)"
phv00022667,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE (LIT./SEC.) - BEST EFFORT"
phv00022683,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE (LIT./SEC.) - BEST EFFORT"
phv00022692,"Framingham Cohort","MAXIMUM MID EXPIRATORY FLOW RATE (LIT./SEC.) - BEST EFFORT"
phv00073838,"Framingham Cohort","Maximum mid expiratory flow rate - best effort"
phv00196558,"Framingham Cohort","Maximum Mid Expiratory Flow Rate (FEF25-75) - Best Effort"
phv00196592,"Framingham Cohort","Maximum Mid Expiratory Flow Rate (FEF25-75) - Best Effort, Albuterol"
phv00169394,"Genetic Epidemiology of COPD (COPDGene)","FEF 25-75 post-bronch"
phv00169397,"Genetic Epidemiology of COPD (COPDGene)","FEF 25-75 pre-bronch"
phv00066571,"Genome-Wide Association Study of Serum YKL-40 Levels","Forced expiratory flow between 25% and 75% of the forced vital capacity (FVC)"
phv00128212,"Jackson Heart Study (JHS) Cohort","BEST_2575 - FEF 25-75 (mid flow) from the best curve: measured in liters"
phv00128222,"Jackson Heart Study (JHS) Cohort","SCND_2575 - FEF 25-75 (mid flow) from the 2nd best curve: measured in"
phv00128232,"Jackson Heart Study (JHS) Cohort","THRD_2575 - FEF 25-75 (mid flow) from the 3rd best curve: measured in liters"
phv00083478,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort","FORCED EXPIRATORY FLOW 25% TO 75% (ml/sec)"
phv00083713,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort","FORCED EXPIRATORY FLOW 25% TO 75% (ml/sec)"
phv00087704,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort","FORCED EXPIRATORY FLOW 25% TO 75% (ml/sec)"